Hutchmed Regulatory News (HCM)

22 May 2007 07:00

Hutchison China Meditech Limited22 May 2007 Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) Director's Shareholding London: Tuesday, 22 May 2007: Chi-Med was informed on 18 May 2007 that Mr.Christian Hogg, Executive Director and Chief Executive Officer of Chi-Med,purchased 70,000 ordinary shares of US$1 each in Chi-Med (the "Shares") at aprice of 153p each on 18 May 2007. Following this purchase, Mr. Hogg is beneficially interested in 170,000 Sharesand vested option to subscribe for up to 384,091 Shares, representingapproximately 1.1% of the current issued share capital of Chi-Med. Ends Enquiries Chi-Med Telephone: +852 2121 8200 Christian Hogg, CEO Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571 Anthony Carlisle Mobile: +44 (0) 7973 611 888 Yvonne Alexander Mobile: +44 (0) 7866 610 682 About Chi-Med Chi-Med is the holding company of a pharmaceutical and healthcare group basedprimarily in China and was admitted to trading on the Alternative InvestmentMarket of the London Stock Exchange in May 2006. Chi-Med is focused onresearching, developing, manufacturing, and selling pharmaceuticals, healthsupplements and other consumer health and personal care products derived fromTraditional Chinese Medicine and botanical ingredients. Chi-Med is majority owned by Hutchison Whampoa Limited, an internationalcorporation listed on the Main Board of The Stock Exchange of Hong Kong Limited. This information is provided by RNS The company news service from the London Stock Exchange